Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael F Duarte

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Frontiers in Immunology|May 1, 2020
Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT - A Prospective, Non-interventional Study of the EBMT Transplant Complications Working PartyOlaf Penack, Christophe Peczynski, Steffie van der Werf, et al.
Vox Sanguinis|February 3, 2023
Pathogen reduction with methylene blue does not have an impact on the clinical effectiveness of COVID-19 convalescent plasmaIrene Romera Martínez, José Luis Bueno Cabrera, José María Domingo-Morera, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 1, 2025
Allogeneic haematopoietic cell transplant in cutaneous T-cell lymphomas: Recommendations from the EBMT PH&G CommitteeGandhi Damaj, Adèle de Masson, Peter Dreger, et al.
Bone Marrow Transplantation|October 1, 2025
Allogeneic hematopoietic cell transplant in cutaneous T-cell lymphomas: recommendations from the EBMT PH&G CommitteeGandhi Damaj, Adèle de Masson, Peter Dreger, et al.
Vox Sanguinis|November 21, 2023
Factors related to the development of high antibody titres against SARS-CoV-2 in convalescent plasma donors from the ConPlas-19 trialIrene Romera Martínez, Cristina Avendaño-Solá, Carolina Villegas Da Ros, et al.
Frontiers in Immunology|February 19, 2021
Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell MalignanciesAgnieszka Tomaszewska, Madan Jagasia, Eric Beohou, et al.
Critical Reviews in Microbiology|January 11, 2019
Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope<sup>®</sup>Danila Seidel, Arne Meißner, Michaela Lackner, et al.
JAMA Network Open|January 25, 2022
Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19: A Meta-analysisAndrea B Troxel, Eva Petkova, Keith Goldfeld, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 23, 2014
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group reportMadan H Jagasia, Hildegard T Greinix, Mukta Arora, et al.
Bone Marrow Transplantation|October 27, 2018
Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMTIvan S Moiseev, Tatyana Tsvetkova, Mahmoud Aljurf, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Frontiers in Immunology|May 1, 2020
Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT - A Prospective, Non-interventional Study of the EBMT Transplant Complications Working PartyOlaf Penack, Christophe Peczynski, Steffie van der Werf, et al.
Vox Sanguinis|February 3, 2023
Pathogen reduction with methylene blue does not have an impact on the clinical effectiveness of COVID-19 convalescent plasmaIrene Romera Martínez, José Luis Bueno Cabrera, José María Domingo-Morera, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 1, 2025
Allogeneic haematopoietic cell transplant in cutaneous T-cell lymphomas: Recommendations from the EBMT PH&G CommitteeGandhi Damaj, Adèle de Masson, Peter Dreger, et al.
Bone Marrow Transplantation|October 1, 2025
Allogeneic hematopoietic cell transplant in cutaneous T-cell lymphomas: recommendations from the EBMT PH&G CommitteeGandhi Damaj, Adèle de Masson, Peter Dreger, et al.
Vox Sanguinis|November 21, 2023
Factors related to the development of high antibody titres against SARS-CoV-2 in convalescent plasma donors from the ConPlas-19 trialIrene Romera Martínez, Cristina Avendaño-Solá, Carolina Villegas Da Ros, et al.
Frontiers in Immunology|February 19, 2021
Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell MalignanciesAgnieszka Tomaszewska, Madan Jagasia, Eric Beohou, et al.
Critical Reviews in Microbiology|January 11, 2019
Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope<sup>®</sup>Danila Seidel, Arne Meißner, Michaela Lackner, et al.
JAMA Network Open|January 25, 2022
Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19: A Meta-analysisAndrea B Troxel, Eva Petkova, Keith Goldfeld, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 23, 2014
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group reportMadan H Jagasia, Hildegard T Greinix, Mukta Arora, et al.
Bone Marrow Transplantation|October 27, 2018
Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMTIvan S Moiseev, Tatyana Tsvetkova, Mahmoud Aljurf, et al.
Pageof 12